mechanism of glp-1 receptor agonists Glucagon-like peptide 1 agonists: cardiovascular benefits and mechanisms action Nephroprotective effects of GLP-1 receptor

It contributes to blood glucose control by stimulating glucose-dependent insulin secretion, inhibiting glucagon release, delaying gastric emptying, and reducing appetite

311, C572C582

doi: 10.3389/fendo.2020.00178

Alzheimers disease pharmacotherapy in relation to cholinergic system involvement

Once daily injectable liraglutide (marketed as Victoza for T2DM and Saxenda for obesity) and once weekly injectable semaglutide (marketed as Ozempic for T2DM and Wegovy for obesity) are two additional GLP-1 analogues, sharing 97% and 94% amino acid homology to GLP-1, respectively [ Figure 2 , Table 1 ]

Conflicts of interest The authors have no conflicts of interest to disclose